Showing 36,902 results

Filters
HIV treatment

Clinical and immunological benefits lasting at least three years reported by large Kenyan antiretroviral programme

News
10 January 2006
Starting treatment

ICAAC: Nevirapine’s manufacturer examines rates of liver toxicity in key study, finds once daily dose equally safe at lower CD4 count

News
9 January 2006
Sexually transmitted infections epidemiology

ICAAC: Women who shed HSV in genitals shed more HIV

News
9 January 2006
Hepatitis & HIV

ICAAC: HCV only factor associated with liver problems in patients starting HIV treatment in 2004

News
9 January 2006
HIV treatment

ICAAC: Dividing Triomune tablets may result in inadequate doses for small children; liquid best

News
6 January 2006
People with limited treatment options

ICAAC: TMC114 shows further promise in second POWER study

News
6 January 2006
Transmission & prevention

Ugandan ART programme claims to reduce sexual risk taking and the risk of HIV transmission

News
6 January 2006
Testing & health monitoring

ICAAC: Studies look at risk factors for cell changes in anus and cervix

News
5 January 2006
Treatment outcomes & life expectancy

ICAAC: Factors unrelated to HIV or side-effects of HIV treatment major cause of illness in French cohort

News
5 January 2006
Treatment interruptions

ICAAC: Viral load between six to 18 months predicts longer-term success of HIV therapy

News
5 January 2006
Starting treatment

ICAAC: Pilot study shows dual protease inhibitor regimen as safe and effective as traditional two class HIV therapy

News
4 January 2006
Side effects

ICAAC: New treatment for lipid problems shows promise in HIV patients

News
4 January 2006
TB treatment

ICAAC: TB patients with good CD4 cell counts can safely defer HIV treatment

News
4 January 2006
New & experimental HIV treatments

ICAAC: Early trials involving new GSK protease inhibitor have encouraging results

News
20 December 2005
Resistance

ICAAC: Nevirapine still present in breastmilk two weeks after last dose

News
20 December 2005
New & experimental HIV treatments

ICAAC: Achillion reveals potential for once weekly dosing of nucleoside analogue

News
20 December 2005
HIV treatment

South African study finds many patients die waiting for treatment after enrolment into antiretroviral rollout programme

News
20 December 2005

ICAAC: No added benefit from adding AZT to nevirapine to prevent MTCT

News
19 December 2005
PEP

UK Government to be sued over lack of PEP policy for sexual exposure to HIV

News
19 December 2005
TB treatment

ICAAC: Nevirapine and rifampicin can be safely used together

News
19 December 2005
TB treatment

ICAAC: Moxifloxacin as effective as ethambutol in TB treatment

News
19 December 2005

New study looks at impact of AIDS on South Africa

News
18 December 2005
HIV treatment

Advocacy groups demand equal HIV treatment access for injecting drug users

News
15 December 2005
Weight gain & lipodystrophy

Limb fat gains lower when switching from AZT to abacavir or tenofovir, compared with d4T

News
15 December 2005